Overview

GW117 ODT Orally Disintegrating Tablets Safety and Pharmacokinetics Study in Healthy Subjects

Status:
COMPLETED
Trial end date:
2023-03-24
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of GW117 ODT in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Beijing Greatway Pharmaceutical Technology Co.,Ltd.